The Neuromodulationmarket was valued at US$ 7,613.45 million in 2019 and is projected to reach US$ 16,333.98 million by 2027; it is expected to grow at a CAGR of 10.3%during 2020–2027.
Neurological disorders such as cerebrovascular diseases, Alzheimer’s disease, and Parkinson's disease can be treated with the help of neuromodulation that is performed by using various devices or infusing drugs. Devices used in neuromodulation Market involve the application of electrodes to the spinal cord, brain, or peripheral nerves.
Lucrative Regions in Neuromodulation Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Incidence of Neurological Disorders Drives Market Growth
Depression is the most common neurological disorder among all age groups. In the developing regions, most people suffer from depression owing to various socioeconomic factors such as financial stress and poverty. Other neurological disorders such as dystonia, Parkinson’s disease, and obsessive-compulsive disorder are usually observed in aging population. According to a study ‘Incidence and Prevalence of Major Neurologic Disorders,’ published in January 2018, ~36% of elderly have moderate or severe memory impairment in the US. Each year nearly 1.2 million adults are diagnosed with brain disorders, of which 51.3% is due to stroke and 21% due to Alzheimer’s disease. In addition, nearly 135 million people are diagnosed with Parkinson’s disease, traumatic brain injury, and epilepsy each year. Moreover, ~500,000 cases of brain tumor, multiple sclerosis, and amyotrophic lateral sclerosis are reported annually. Therefore, the growing prevalence of neurological disorders is consequently propelling the demand for neuromodulators as these help in relieving neurological symptoms. Furthermore, the rising demand for neurostimulation devices to treat chronic pain.
Products Insights
In terms of technology, the external (non-invasive) neuromodulation segment held a greater share of the neuromodulation market in 2019. The same segment is expected to continue its dominance and register a higher CAGR in the market during the forecast period.
Neuromodulation Market, by Technology – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application Insights
Based on application, the global neuromodulation market is segmented into chronic pain management, failed back syndrome, epilepsy, tremor, incontinence, depression, dystonia, gastroparesis, Parkinsons’s disease, obsessive-compulsive disorder, and migraine. The chronic pain management segment held the largest share of the market in 2019, and it is expected to register the highest CAGR during the forecast period.
Chronic pain management helps relieve pain with the use of drugs, therapies, and lifestyle changes. Electrical stimulation devices play a major role in pain management as they are primarily developed for relieving several types of chronic and acute pain.Growing geriatric population, increasing chronic condition prevalence, and sedentary lifestyle are a few of the risk factors that may cause chronic pain. For instance, according to a study published by Arthritis Foundation in 2019, aging population is responsible for the growing prevalence of all types of diseases across the world. The same study stated that1 in 3 people in the US suffers from arthritis each year. Therefore, the rising prevalence of chronic pain is expected to drive the growth of the segment during the forecast period.
The incorporation of advanced technologies in electrical stimulation devices enables additional benefits for pain management. For instance, in January 2019, Abbott announced test results of BurstDR stimulation developed for the treatment of chronic pain. The results show thatthe product reduces pain by around 60–70%.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Neuromodulation Market: Strategic Insights
Market Size Value in US$ 7,613.45 Million in 2019 Market Size Value by US$ 16,333.98 Million by 2027 Growth rate CAGR of 10.3% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Neuromodulation Market: Strategic Insights
| Market Size Value in | US$ 7,613.45 Million in 2019 |
| Market Size Value by | US$ 16,333.98 Million by 2027 |
| Growth rate | CAGR of 10.3% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
By Technology
- External (Non-Invasive) Neuromodulation
- Respiratory Electrical Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Internal Neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- Spinal Cord Stimulation
- Vagus Nerve Stimulation
By Application
- Chronic Pain Management
- Failed Back Syndrome
- Epilepsy
- Tremor
- Incontinence
- Depression
- Dystonia
- Gastroparesis
- Parkinson’s Disease
- Obsessive-Compulsive Disorder
- Migraine
By End User
- Hospitals
- Clinics
- Home Healthcare
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Russia
Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
South and Central America
- Brazil
- Argentina
Company Profiles
- Abbott
- Boston Scientific Corporation
- Medtronic
- NeuroPace, Inc.
- NeuroSigma, Inc.
- NEVRO CORP.
- Synapse Biomedical Inc.
- Soterix Medical Inc
- Integer Holdings Corporation
- Magstim
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology Neuromodulation ; Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.
The global neuromodulation market is being driven by factors such as increasing incidence of neurological disorders, growing developments in neuromodulation technology. Furthermore, rising demand for neurostimulation devices to treat chronic pain is likely to offer significant opportunities for the growth of the global neurostimulation market.
The high cost of neuromodulation devices is the significant factor that will hinder the neuromodulation market growth.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Neuromodulation Market – By Technology
1.3.2 Neuromodulation Market – By Application
1.3.3 Neuromodulation Market – By End User
1.3.4 Global Neuromodulation Market – By Geography
2. Neuromodulation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Neuromodulation– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Neuromodulation Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Neurological Disorders
5.1.2 Growing Developments in Neuromodulation Technology
5.2 Market Restraints
5.2.1 High Cost of Neuromodulation Devices
5.3 Market Opportunities
5.3.1 Rising Demand for Neurostimulation Devices to Treat Chronic Pain
5.4 Future Trends
5.4.1 Technological Advancements
5.5 Impact Analysis
6. Neuromodulation Market– Global Analysis
6.1 Global Neuromodulation Market Revenue Forecast and Analysis
6.2 Global Neuromodulation Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Neuromodulation Market Analysis – By Technology
7.1 Overview
7.2 Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
7.3 External Neuromodulation
7.3.1 Overview
7.3.2 External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.3.3 Respiratory Electrical Stimulation (RES)
7.3.3.1 Overview
7.3.3.2 Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)
7.3.4.1 Overview
7.3.4.2 Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.3.5 Transcranial Magnetic Stimulation (TMS)
7.3.5.1 Overview
7.3.5.2 Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Internal Neuromodulation
7.4.1 Overview
7.4.2 Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.4.3 Deep Brain Stimulation (DBS)
7.4.3.1 Overview
7.4.3.2 Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.4.4 Sacral Nerve Stimulation (DBS)
7.4.4.1 Overview
7.4.4.2 Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.4.5 Gastric Electric Stimulation (GES)
7.4.5.1 Overview
7.4.5.2 Gastric Electric Stimulation (GES): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.4.6 Spinal Cord Stimulation (SCS)
7.4.6.1 Overview
7.4.6.2 Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
7.4.7 Vagus Nerve Stimulation (VNS)
7.4.7.1 Overview
7.4.7.2 Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
8. Neuromodulation Market Analysis – By Application
8.1 Overview
8.2 Neuromodulation Market Share, by Application, 2019 and 2027 (%)
8.3 Chronic Pain Management
8.3.1 Overview
8.3.2 Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
8.4 Failed Back Syndrome
8.4.1 Overview
8.4.2 Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
8.5 Epilepsy
8.5.1 Overview
8.5.2 Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
8.6 Tremor
8.6.1 Overview
8.6.2 Tremor: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
8.7 Incontinence
8.7.1 Overview
8.7.2 Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Depression
8.8.1 Overview
8.8.2 Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.9 Dystonia
8.9.1 Overview
8.9.2 Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.10 Gastroparesis
8.10.1 Overview
8.10.2 Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.11 Parkinson’s Disease
8.11.1 Overview
8.11.2 Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.12 Obsessive-Compulsive Disorder (OCD)
8.12.1 Overview
8.12.2 Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
8.13 Migraine
8.13.1 Overview
8.13.2 Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
9. Neuromodulation Market Analysis – By End User
9.1 Overview
9.2 Neuromodulation Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Home Healthcare
9.5.1 Overview
9.5.2 Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
10. Neuromodulation Market Analysis and Forecasts To 2027 – Geographical Analysis
10.1 North America: Neuromodulation Market
10.1.1 Overview
10.1.2 North America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.3.1 North America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.3.2 North America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Neuromodulation Market, by Country, 2019 & 2027 (%)
10.1.7 US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.7.2.1 US: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.2.2 US: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.8.2.1 Canada: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.2.2 Canada: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.9.2.1 Mexico: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.2.2 Mexico: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Neuromodulation Market
10.2.1 Overview
10.2.2 Europe: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.3.1 Europe: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.3.2 Europe: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.5 Europe: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Neuromodulation Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.7.2.1 Germany: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.7.2.2 Germany: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.7.4 Germany: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.8.2.1 UK: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.8.2.2 UK: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)10.2.8.3 UK: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.8.4 UK: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.9.2.1 France: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.9.2.2 France: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.9.4 France: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.10.2.1 Spain: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.10.2.2 Spain: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.10.4 Spain: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.11.2.1 Italy: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.11.2.2 Italy: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Italy: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Neuromodulation Market
10.3.1 Overview
10.3.2 Asia Pacific: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.3.1 Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.3.2 Asia Pacific: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia Pacific: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia Pacific: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)
10.3.7 China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.7.2.1 China: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.7.2.2 China: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.7.4 China: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.8.2.1 Japan: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.8.2.2 Japan: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.8.4 Japan: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.9.2.1 India: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.9.2.2 India: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.9.4 India: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.10.2.1 South Korea: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.10.2.2 South Korea: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.10.4 South Korea: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.11.2.1 Australia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.11.2.2 Australia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.11.4 Australia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4 Middle East and Africa: Neuromodulation Market
10.4.1 Overview
10.4.2 Middle East and Africa: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
10.4.3 Middle East and Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.4.3.1 Middle East and Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.3.2 Middle East and Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East and Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East and Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East and Africa: Neuromodulation Market, by Country, 2019 & 2027 (%)
10.4.7 Saudi Arabia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.4.7.2.1 Saudi Arabia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.7.2.2 Saudi Arabia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Saudi Arabia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Saudi Arabia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4.8 UAE: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.4.8.2.1 UAE: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.8.2.2 UAE: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.8.3 UAE: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.8.4 UAE: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.4.9.2.1 South Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.9.2.2 South Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.9.4 South Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Neuromodulation Market
10.5.1 Overview
10.5.2 South and Central America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.5.3.1 South and Central America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.3.2 South and Central America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.5.7.2.1 Brazil: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.7.2.2 Brazil: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.5.8.2.1 Argentina: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.8.2.2 Argentina: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Neuromodulation Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Neuromodulation Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Boston Scientific Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medtronic
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 NeuroPace, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 NeuroSigma, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 NEVRO CORP.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Synapse Biomedical Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Soterix Medical Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Integer Holdings Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Magstim
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms
LIST OF TABLES
Table 1. North America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 2. North America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. North America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. US: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 7. US: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. US: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 9. US: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. US: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 13. Canada: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Canada: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. Canada: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 17. Mexico: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Mexico: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Mexico: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. Mexico: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 21. Europe: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 22. Europe: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. Europe: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 24. Europe: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. Europe: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 26. Germany: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 27. Germany: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 28. Germany: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. Germany: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 30. Germany: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 31. UK: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 32. UK: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 33. UK: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 34. UK: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 35. UK: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 36. France: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 37. France: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 38. France: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 39. France: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 40. France: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 41. Spain: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 42. Spain: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 43. Spain: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 44. Spain: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 45. Spain: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 46. Italy: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 47. Italy: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 48. Italy: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 49. Italy: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 50. Italy: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 51. Asia Pacific: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 52. Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 53. Asia Pacific: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 54. Asia Pacific: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 55. Asia Pacific: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 56. China: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 57. China: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 58. China: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 59. China: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 60. China: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 61. Japan: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 62. Japan: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 63. Japan: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 64. Japan: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 65. Japan: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 66. India: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 67. India: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 68. India: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 69. India: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 70. India: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 71. South Korea: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 72. South Korea: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 73. South Korea: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 74. South Korea: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 75. South Korea: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 76. Australia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 77. Australia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 78. Australia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 79. Australia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 80. Australia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 81. Middle East and Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 82. Middle East and Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 83. Middle East and Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 84. Middle East and Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 85. Middle East and Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 86. Saudi Arabia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 87. Saudi Arabia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 88. Saudi Arabia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 89. Saudi Arabia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 90. Saudi Arabia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 91. UAE: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 92. UAE: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 93. UAE: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 94. UAE: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 95. UAE: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 96. South Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 97. South Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 98. South Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 99. South Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 100. South Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 101. South and Central America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 102. South and Central America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 103. South and Central America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 104. South and Central America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 105. South and Central America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 106. Brazil: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 107. Brazil: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 108. Brazil: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 109. Brazil: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 110. Brazil: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 111. Argentina: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 112. Argentina: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 113. Argentina: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 114. Argentina: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 115. Argentina: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 116. Organic Developments Done by Companies
Table 117. Inorganic Developments Done by Companies
Table 118. Glossary of Terms, Neuromodulation Market
LIST OF FIGURES
Figure 1. Neuromodulation Market Segmentation
Figure 2. Neuromodulation Market – By Geography
Figure 3. Global Neuromodulation Market Overview
Figure 4. Internal Neuromodulation Segment Held Largest Share of Product Type Segment in Neuromodulation Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Neuromodulation Market, By Geography (US$ Million)
Figure 7. Global Neuromodulation Market- Leading Country Markets (US$ Million)
Figure 8. Global Neuromodulation Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Neuromodulation Market Impact Analysis of Drivers and Restraint
Figure 15. Global Neuromodulation Market– Revenue Forecast and Analysis – 2019- 2027
Figure 16. Global Neuromodulation Market– By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning of Key Players in Global Neuromodulation Market
Figure 18. Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
Figure 19. External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 20. Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 21. Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 22. Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 23. Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 24. Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 25. Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 26. Gastric Electric Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 27. Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 28. Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 29. Neuromodulation Market Share, by Application, 2019 and 2027 (%)
Figure 30. Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 31. Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 32. Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)
Figure 33. Tremor: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 35. Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 36. Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 37. Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 38. Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 39. Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 40. Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 41. Neuromodulation Market Share, by End User, 2019 and 2027 (%)
Figure 42. Hospitals Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 43. Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 44. Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
Figure 45. North America: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)
Figure 46. North America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
Figure 47. North America: Neuromodulation Market, by Country, 2019 & 2027 (%)
Figure 48. US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Europe: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)
Figure 52. Europe: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
Figure 53. Europe: Neuromodulation Market, by Country, 2019 & 2027 (%)
Figure 54. Germany: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. UK: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 56. France: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 57. Spain: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. Italy: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. Asia Pacific: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)
Figure 60. Asia Pacific: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
Figure 61. Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)
Figure 62. China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 63. Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 66. Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 67. Middle East and Africa: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)
Figure 68. Middle East and Africa: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
Figure 69. Middle East and Africa: Neuromodulation Market, by Country, 2019 & 2027 (%)
Figure 70. Saudi Arabia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 71. UAE: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 72. South Africa: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 73. South and Central America: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)
Figure 74. South and Central America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
Figure 75. South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)
Figure 76. Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 77. Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)
Figure 78. Impact of COVID-19 Pandemic in North American Country Markets
Figure 79. Impact of COVID-19 Pandemic in European Country Markets
Figure 80. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 81. Impact of COVID-19 Pandemic in Rest of the World Country Market
Figure 82. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Neuromodulation Market
- Abbott
- Boston Scientific Corporation
- Medtronic
- NeuroPace, Inc.
- NeuroSigma, Inc.
- NEVRO CORP.
- Synapse Biomedical Inc.
- Soterix Medical Inc
- Integer Holdings Corporation
- Magstim
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Neuromodulation Market
Oct 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Oct 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Oct 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)